Influenza News and Research

Latest Influenza News and Research

Hidden viral reservoirs in tonsils may explain school-year respiratory outbreaks

A study conducted at the University of São Paulo (USP) in Brazil reveals that tissues such as the tonsils and adenoids can serve as hiding places for the rhinovirus, which causes the common cold and is responsible for most respiratory infections worldwide.

17 Apr 2026

Scientists warn of a silent surge in resistant Aspergillus and Candida

An increasing number of fungi are becoming resistant to medication, posing serious risks for patients with weakened immune systems. That is why fifty researchers from around the world, led by Radboudumc, are calling for action against drug‑resistant fungi. Their call has been published in Nature Medicine.

17 Apr 2026

New flu vaccine approach targets multiple virus strains

Doctors recommend getting your flu shot annually, since the specific influenza strain it targets varies from year to year. But what if the shot could be more effective while protecting against more strains?

15 Apr 2026

NTU Singapore and partners develop new inhaled treatment for severe lung infections

Nanyang Technological University, Singapore (NTU Singapore) is working with China's Southern University of Science and Technology (SUSTech) and Swedish biotechnology company Lipigon Pharmaceuticals AB to develop a new inhaled treatment aimed at helping patients recover faster from severe lung infections.

13 Apr 2026

Nanodisc technology improves study of viral proteins for vaccines

Viruses are masters at invading our cells thanks to specialized proteins that coat their surfaces. When scientists design vaccines, they often create versions of these viral surface proteins to study how our immune systems might respond.

11 Apr 2026

Dynamic AI models detect body tipping points to forecast disease before symptoms

The editorial, "Dynamics-driven medical big data mining: dynamic approaches to early disease forecasting and individualized care," published in Intelligent Medicine (February 2026, Volume 6, Issue 1), was written by Lu Wang (Tianjin Medical University), Han Lyu (Beijing Friendship Hospital, Capital Medical University), and Bin Sheng (Shanghai Jiao Tong University).

10 Apr 2026

Flu vaccines protect children well across Europe, but H3N2 remains harder to stop

Influenza vaccination provided strong real-world protection for children in European primary care across two seasons, with overall vaccine effectiveness of 68% in 2022–2023 and 71% in 2023–2024. Protection was highest against influenza B and H1N1, while H3N2 showed lower and more variable effectiveness, supporting the need for higher uptake and continued monitoring.

8 Apr 2026

High-dose flu vaccine reduces Alzheimer’s risk in older adults

A study reveals high-dose influenza vaccines could modestly reduce Alzheimer's risk in older adults, especially women, offering new insights into prevention.

8 Apr 2026

One Health Summit drives a new wave of coordinated action for global health threats

On World Health Day, global leaders gathered in France for a milestone "One Health Summit", where the World Health Organization (WHO) and partners announced a new wave of concrete actions to better protect people, animals and the planet from future health crises.

7 Apr 2026

Waterfowl movement patterns influence spread of avian influenza outbreaks

The movement patterns of waterfowl, including ducks, swans and geese, may affect the spread of highly pathogenic avian influenza in bird populations, according to a new study from the University of Georgia.

7 Apr 2026

Flu vaccination may cut heart attack and stroke risk after infection

In Danish adults aged 40 years or older, laboratory-confirmed influenza was linked to a sharp short-term rise in first-time heart attack and stroke risk, especially in the first 7 days after infection. Prior same-season influenza vaccination was associated with about half the excess cardiovascular risk among infected individuals, suggesting possible protection even in breakthrough cases.

6 Apr 2026

Novel mucosal vaccine offers broad protection against diverse influenza viruses

A novel vaccine platform has been developed to induce broad, protective immunity against numerous influenza virus infections, showing promise as an effective mucosal vaccine strategy, according to a study published by researchers in the Institute for Biomedical Sciences at Georgia State University.

3 Apr 2026

High-dose flu shots inked to lower Alzheimer's dementia risk in older adults

A large US claims-based study found that adults aged 65 and older who received a high-dose flu vaccine had a lower observed risk of Alzheimer dementia than those who received a standard-dose vaccine, with the association lasting up to 25 months in per-protocol analyses and 28 months in intention-to-treat analyses. The signal appeared stronger and more sustained in women, though the authors stress that the findings are observational and need confirmation in longer prospective studies.

2 Apr 2026

Flu vaccine halves heart attack risk after breakthrough infection

Influenza vaccination could significantly reduce the risk of influenza-associated heart attack and stroke even among people who get infected after getting the vaccine, according to research just published in Eurosurveillance.

2 Apr 2026

High-dose flu vaccine linked to lower Alzheimer’s disease risk

A UTHealth Houston physician's visit to a local public health building sparked community awareness and inspired a new research idea.

1 Apr 2026

Rapid antiviral treatment reduces nursing home hospitalizations during flu outbreaks

In nursing homes, influenza spreads quickly. Even in facilities with separate wings, staff move throughout the home, caring for medically complex older adults who often share rooms.

31 Mar 2026

New T cell mechanism could lead to longer-lasting vaccines

Researchers at the University of Wisconsin School of Veterinary Medicine have identified a possible way to make longer lasting vaccines for respiratory viruses like influenza and the coronavirus that causes COVID-19.

31 Mar 2026

Natural peptide in sweat may help block flu infection before symptoms start

Researchers led by the Fisabio Foundation found that dermcidin, a natural antimicrobial peptide present in sweat and respiratory tissues, can block influenza infection by binding to a highly conserved region of the viral hemagglutinin protein and preventing cell entry. The study also found that people who did not develop flu-like symptoms had markedly higher baseline dermcidin levels, suggesting the molecule may help reduce susceptibility to infection and could support the development of broader-spectrum antivirals.

30 Mar 2026

New clinical guideline adopts holistic approach to brain and heart health

A new brain–heart clinical practice guideline takes a holistic approach, integrating neurologic and mental health evidence with guidance for cardiovascular disease as many brain and heart conditions overlap and share similar risk factors.

30 Mar 2026

New study maps global immune gene diversity across multiple populations

Inherited variations in antibody genes can affect how we respond to infections and vaccines, show two new studies from Karolinska Institutet in Sweden, published in the journal Immunity.

26 Mar 2026